Adds illicit fentanyls to Schedule I in the "New Jersey Controlled Dangerous Substances Act."
Impact
The bill's enactment will significantly modify existing state law regarding the control and regulation of dangerous substances. Currently, illicit fentanyls have already been targeted by an emergency order issued by the Office of the Attorney General, which placed several of these substances into Schedule I in September 2016. Thus, this bill not only aligns statutory provisions with prior administrative actions but also aims to strengthen legal enforcement against the manufacture and distribution of these highly addictive substances.
Summary
Senate Bill S2155 seeks to categorize 'illicit fentanyls' under Schedule I of the New Jersey Controlled Dangerous Substances Act. This legislation aims to address the growing public health crisis related to the illegal use of fentanyl derivatives, which are known for their high potential for abuse and lack of accepted medical use. By formally adding these substances to Schedule I, the bill underscores the state's commitment to combating the opioid epidemic and enhancing public health safety.
Contention
Notably, prescription fentanyl, an important medication for pain management, will retain its classification as a Schedule II substance under the new law. It is crucial to distinguish between illicit and legitimate medical uses to ensure that patients requiring pain management do not face undue restrictions. The bill thus raises discussions among healthcare providers and public health advocates about balancing effective treatment options while combating substance abuse within the community. Stakeholders may express concern over potential conflicts between enforcement and patient access to necessary medications.